MarketCap
Facebook
X
TelegramQuarterly report 2026-Q1
added 04-28-2026
Country |
 USA |
IPO year |
- |
Industry |
Diagnostics research |
Stock Exchange |
NASDAQ GLOBAL |
Shares |
694 M |
Market Cap[1] |
$ 986 M |
EBITDA (LTM) |
$ -71.1 M |
P/E (LTM) |
-3.53 |
P/S (LTM) |
1.3 |
EPS (LTM) |
-0.32 |
Other stocks of industry "Diagnostics research"
| Issuer | Price | % 24h | Market Cap | Exchange | Country | |
|---|---|---|---|---|---|---|
 |
Enzo Biochem
ENZ
|
- | -8.98 % | $ 14.8 K | NYSE | USA |
 |
Centogene N.V.
CNTG
|
- | -6.23 % | $ 30.6 M | Nasdaq Global Market |  Germany |
 |
Heska Corporation
HSKA
|
- | - | $ 1.31 B | Nasdaq Capital Market,SPB | USA |
 |
DermTech
DMTK
|
- | -11.32 % | $ 2.94 M | Nasdaq Capital Market,SPB | USA |
 |
Quest Diagnostics Incorporated
DGX
|
$ 203.06 | -0.38 % | $ 22.5 B | NYSE,SPB | USA |
 |
Celcuity
CELC
|
$ 88.55 | -1.05 % | $ 4.14 B | Nasdaq Global Select Market | USA |
|
Akumin
AKU
|
- | -17.87 % | $ 25.9 M | Nasdaq Capital Market |  Canada |
 |
Co-Diagnostics
CODX
|
$ 4.29 | -8.72 % | $ 5.71 M | Nasdaq Capital Market | USA |
 |
Fulgent Genetics
FLGT
|
$ 18.68 | -0.53 % | $ 575 M | Nasdaq Global Market | USA |
 |
Castle Biosciences
CSTL
|
$ 20.7 | -1.48 % | $ 600 M | Nasdaq Global Market,SPB | USA |
 |
Aspira Women's Health
AWH
|
- | -6.19 % | $ 10.5 M | Nasdaq Capital Market,SPB | USA |
 |
Accelerate Diagnostics
AXDX
|
- | -61.36 % | $ 2.46 M | Nasdaq Global Select Market | USA |
 |
Biocept
BIOC
|
- | -13.05 % | $ 7.29 M | Nasdaq Capital Market | USA |
 |
ICON Public Limited Company
ICLR
|
$ 146.18 | -2.49 % | $ 11.5 B | Nasdaq Global Select Market,SPB |  Irlanda |
 |
Oxford Immunotec Global PLC
OXFD
|
- | - | $ 562 M | Nasdaq Global Select Market |  Britain |
 |
Guardant Health
GH
|
$ 131.62 | 0.55 % | $ 16.5 B | Nasdaq Global Select Market,SPB | USA |
 |
CareDx, Inc
CDNA
|
$ 22.97 | -2.92 % | $ 1.22 B | Nasdaq Global Market,SPB | USA |
 |
Chembio Diagnostics
CEMI
|
- | 0.22 % | $ 16.8 M | Nasdaq Capital Market | USA |
 |
Check-Cap Ltd.
CHEK
|
- | - | $ 9.42 M | Nasdaq Capital Market |  Israel |
 |
Interpace Biosciences
IDXG
|
$ 1.6 | -3.03 % | $ 7.08 M | Nasdaq Global Select Market | USA |
 |
Illumina
ILMN
|
$ 160.97 | -3.15 % | $ 25 B | Nasdaq Global Select Market,SPB | USA |
 |
HTG Molecular Diagnostics
HTGM
|
- | -20.0 % | $ 1.06 M | Nasdaq Capital Market | USA |
 |
Global Cord Blood Corporation
CO
|
- | - | $ 399 M | NYSE |  China |
 |
National Research Corporation
NRC
|
$ 18.79 | - | $ 421 M | Nasdaq Global Select Market | USA |
 |
Fluidigm Corporation
FLDM
|
- | 1.08 % | $ 308 M | Nasdaq Global Select Market | USA |
 |
Natera
NTRA
|
$ 212.07 | -3.27 % | $ 29 B | Nasdaq Global Select Market,SPB | USA |
 |
Genetic Technologies Limited
GENE
|
- | - | $ 7.1 B | Nasdaq Capital Market |  Australia |
 |
Genetron Holdings Limited
GTH
|
- | 0.12 % | $ 80.1 M | Nasdaq Global Market | China |
 |
Pacific Biosciences of California
PACB
|
$ 1.31 | -2.96 % | $ 393 M | Nasdaq Global Select Market,SPB | USA |
 |
Lantheus Holdings
LNTH
|
$ 104.52 | 0.19 % | $ 7.05 B | Nasdaq Global Select Market,SPB | USA |
 |
Charles River Laboratories International
CRL
|
$ 187.51 | -0.29 % | $ 9.29 B | NYSE,SPB | USA |
 |
PRA Health Sciences, Inc.
PRAH
|
- | - | $ 10.7 B | Nasdaq Global Select Market | USA |
 |
Medpace Holdings
MEDP
|
$ 467.34 | -1.63 % | $ 13.5 B | Nasdaq Global Select Market,SPB | USA |
 |
Exact Sciences Corporation
EXAS
|
- | - | $ 19.8 B | Nasdaq Capital Market,SPB | USA |
 |
Mettler-Toledo International
MTD
|
$ 1 131.49 | -0.86 % | $ 23.3 B | NYSE,SPB |  Schweiz |
 |
NeoGenomics
NEO
|
$ 11.15 | -2.79 % | $ 1.43 B | Nasdaq Global Select Market,SPB | USA |
 |
Myriad Genetics
MYGN
|
$ 4.33 | -6.48 % | $ 401 M | Nasdaq Global Select Market,SPB | USA |
 |
Personalis
PSNL
|
$ 9.59 | 1.8 % | $ 856 M | Nasdaq Global Select Market | USA |
 |
Koninklijke Philips N.V.
PHG
|
$ 26.46 | 1.34 % | $ 25.1 B | NYSE |  Niderland |
 |
Twist Bioscience Corporation
TWST
|
$ 76.17 | 2.86 % | $ 4.56 B | Nasdaq Global Select Market,SPB | USA |
 |
Senseonics Holdings
SENS
|
$ 7.18 | -2.05 % | $ 300 M | NYSE American | USA |
 |
QIAGEN N.V.
QGEN
|
- | - | $ 10.6 B | NYSE | Niderland |
 |
Soleno Therapeutics
SLNO
|
- | - | $ 2.69 B | Nasdaq Capital Market | USA |
 |
Biomerica
BMRA
|
$ 2.05 | -1.91 % | $ 4.71 M | Nasdaq Capital Market | USA |
 |
Laboratory Corporation of America Holdings
LH
|
$ 266.16 | 0.34 % | $ 22.1 B | NYSE,SPB | USA |
 |
Thermo Fisher Scientific
TMO
|
$ 469.34 | -1.33 % | $ 177 B | NYSE,SPB | USA |
 |
Trinity Biotech plc
TRIB
|
$ 0.65 | -3.7 % | $ 233 M | Nasdaq Global Select Market | Irlanda |
 |
Motus GI Holdings
MOTS
|
- | -34.28 % | $ 263 K | Nasdaq Global Select Market | Israel |
 |
Neogen Corporation
NEOG
|
$ 9.1 | -1.57 % | $ 1.97 B | Nasdaq Global Select Market,SPB | USA |
 |
Invitae Corporation
NVTA
|
- | - | $ 21.2 M | NYSE,SPB | USA |
References
- Pavone, P. (2019). Market capitalization and financial variables: Evidence from Italian listed companies. International Journal of Academic Research Business and Social Sciences, 9(3), 1356-1371.